Unadjusted and adjusted hazard ratio for pre-procedural TIMI 0-2 flow vs. pre-procedural TIMI 3 flow.

Table 4: Unadjusted and adjusted hazard ratio for pre-procedural TIMI 0-2 flow vs. pre-procedural TIMI 3 flow.

Pre TIMI 0-2	Unadjusted hazard ratio (95% CI)	p-value	Adjusted hazard ratio (95% CI)	p-value
≤ 30 day MACE	1.587 [1.132-2.225]	0.007	1.281 [0.894-1.836]	0.177
≤ 30 day CVD	1.681 [1.142-2.476]	0.009	1.233 [0.816-1.862]	0.32
1-year MACE	1.198 [0.975-1.473]	0.086	1.111 [0.893-1.382]	0.334
> 30 day MACE	0.977 [0.752-1.270]	0.864	0.948 [0.720-1.249]	0.705
1-year all-cause death	1.300 [1.011-1.672]	0.041	1.125 [0.861-1.470]	0.387
1-year CVD	1.496 [1.084-2.063]	0.014	1.265 [0.903-1.773]	0.172
> 30 day CVD	0.984 [0.570-1.696]	0.953	1.029 [0.589-1.798]	0.921
MI	0.922 [0.486-1.748]	0.803	1.129 [0.529-2.410]	0.753
RePCI (TVR/TLR)	0.911 [0.633-1.311]	0.616	0.923 [0.632-1.346]	0.923

TIMI: Thrombolysis in Myocardial Infarction; MACE: Major Adverse Cardiac Events; CVD: Cardiovascular Death; TVR: Target Vessel Revascularization; TLR: Target Lesion Revascularization; RePCI: Recurrent Percutaneous Coronary Intervention.

MACE is defined as the composite of the death of any cause, recurrence of MI, TLR, TVR, and CABG. Adjustment : Age, sex , history of hypertension, diabetes, dyslipidemia, and smoking, killip I-II vs. III-IV, multi-vessel disease, lesion type A/B1 vs. B2/C, target vessels, Door to balloon time, CK-MB, Creatinine, use of aspirin, clopidogrel, beta-blocker, RAS blocker, statin at admission.